are now
Press Release
Ampersand Capital Partners Acquires Pacific Biomarkers and Merges Company with NEOMED-LABS
November 19, 2018 | Press Release
WELLESLEY, MA, LAVAL, QC, and SEATTLE, WA, November 19, 2018 - Ampersand Capital Partners announced today that it has completed […]
FDA Qualifies Safety Biomarker Panel Developed and Validated by Pacific Biomarkers for Kidney Injury
September 24, 2018 | Press Release
SEATTLE, WASHINGTON, November 5, 2018 – The U.S. Food and Drug Administration (FDA), announced that the qualification of the Predictive […]
Ampersand Invests in Management Buyout of Clinical Immunology Provider NEOMED-LABS from the NEOMED Institute
September 4, 2018 | Press Release
LAVAL, QC. and WELLESLEY, MA., September 4, 2018 – Ampersand Capital Partners, together with the management team of NEOMED-LABS and […]
NEOMED-LABS Renews Strategic Agreement with GSK
May 31, 2018 | Press Release
Laval, May 31, 2018 – Laval headquartered NEOMED-LABS, a global leader in the clinical immunology field, announces today a 3-year […]